SpringerLink
Log in

Autoantibodies in the grocery shop: does quantity matter?

  • Diagnosis of Autoimmunity
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Testing for autoantibodies is an integrated part in the diagnostic process of many autoimmune diseases. As a consequence, the detection of autoantibodies is increasingly recognized in classification criteria and diagnostic guidelines. In this review, the question is addressed whether quantification of autoantibodies is clinically useful, not only in the diagnostic stage, but also during follow-up of patients with autoimmune diseases. It can be concluded that for a multitude of autoantibodies, there is sufficient evidence that the higher the amount of autoantibodies, the more likely that the patient has the respective autoimmune disease. Quantification is also of added value for monitoring therapeutic efficacy, although this depends on the type of therapy that is installed. The relation between rises in autoantibody levels and the occurrence of subsequent disease relapses, however, is far from absolute. Obviously, if quantification of autoantibodies is performed in the laboratory, results should also be reported quantitatively together with an appropriate interpretation for the clinician.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.

    Article  PubMed  CAS  Google Scholar 

  2. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH. European study group on classification criteria for Sjögren’s syndrome. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis. 2002;61:554–8.

    Article  PubMed  CAS  Google Scholar 

  3. Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, Schiødt M, Umehara H, Vivino F, Zhao Y, Dong Y, Greenspan D, Heidenreich AM, Helin P, Kirkham B, Kitagawa K, Larkin G, Li M, Lietman T, Lindegaard J, McNamara N, Sack K, Shirlaw P, Sugai S, Vollenweider C, Whitcher J, Wu A, Zhang S, Zhang W, Greenspan J, Daniels T. Sjögren’s international collaborative clinical alliance (SICCA) research groups. American college of rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s international collaborative clinical alliance cohort. Arthritis Care Res. 2012;64:475–87.

    Article  CAS  Google Scholar 

  4. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52:148–59.

    Article  PubMed  CAS  Google Scholar 

  5. Alarcon-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. J Rheumatol. 1989;16:328–34.

    PubMed  CAS  Google Scholar 

  6. Kahn MF, Appelboom T. Syndrom de Sharp. In: Kahn MF, Peltier AP, Meyer O, Piette JC, editors. Les maladies systemiques. Paris: Flammarion; 1991. p. 545–56.

    Google Scholar 

  7. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyianopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.

    Article  PubMed  CAS  Google Scholar 

  8. Tozzoli R, Bizzaro N. The clinical autoimmunologist and the laboratory autoimmunologist: the two sides of the coin. Autoimmun Rev. 2012;11:766–70.

    Article  PubMed  Google Scholar 

  9. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JMW, Hobbs K, Huizinga TWJ, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upschurch KS, Vencovský J, Wolfe F, Hawker G. Rheumatoid arthritis classification criteria: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580–8.

    Article  PubMed  Google Scholar 

  10. Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, Troncone R, Giersiepen K, Branski D, Catassi C, Lelgeman M, Mäki M, Ribes-Koninckx C, Ventura A, Zimmer KP. For the ESPGHAN working group on celiac disease diagnosis, on behalf of the ESPGHAN gastroenterology committee. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of celiac disease. JPGN. 2012;54:136–60.

    PubMed  CAS  Google Scholar 

  11. Bossuyt X. Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory. Autoimmun Rev. 2009;8:543–8.

    Article  PubMed  CAS  Google Scholar 

  12. Bossuyt X, Coenen D, Fieuws S, Verschueren P, Westhovens R, Blanckaert N. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor. Ann Rheum Dis. 2009;68:287–9.

    Article  PubMed  CAS  Google Scholar 

  13. Vermeersch P, Blockmans D, Bossuyt X. Use of likelihood ratios can improve the clinical usefulness of enzyme immunoassays for the diagnosis of small-vessel vasculitis. Clin Chem. 2009;55:1886–8.

    Article  PubMed  CAS  Google Scholar 

  14. Vermeersch P, Coenen D, Geboes K, Mariën G, Hiele M, Bossuyt X. Use of likelihood ratios improves clinical interpretation of IgA anti-tTG antibody testing for celiac disease. Clin Chim Acta. 2010;411:13–7.

    Article  PubMed  CAS  Google Scholar 

  15. Mahler M, Radice A, Sinico RA, Damoiseaux J, Seaman A, Buckmelter K, Vizjak A, Buchner C, Binder WL, Fritzler MJ, Cui Z. Performance evaluation of a novel chemiluminescence assay for detection of anti-GBM antibodies: an international multicenter study. Nephrol Dial Transplant. 2012;27:243–52.

    Article  PubMed  CAS  Google Scholar 

  16. Farrugia ME, Vincent A. Autoimmune mediated neuromuscular junction defects. Curr Opin Neurol. 2010;23:489–95.

    Article  PubMed  CAS  Google Scholar 

  17. Losen M, Stassen MH, Martinez-Martinez P, Machiels BM, Duimel H, Frederik P, Veldman H, Wokke JH, Spaans F, Vincent A, De Baets MH. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis. Brain. 2005;128:2327–37.

    Article  PubMed  Google Scholar 

  18. Sugai E, Nachman F, Väguez H, González A, Andrenacci P, Czech A, Niveloni S, Mazure R, Smecuol E, Cabanne A, Mauriño E, Bai JC. Dynamics of celiac disease-specific serology after initiation of a gluten-free diet and use in the assessment of compliance with treatment. Dig Liver Dis. 2010;42:352–8.

    Article  PubMed  CAS  Google Scholar 

  19. Zhong S, Qiu YF, Han BB, Zhao JY, Zhu XJ, Chen XX. Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris. Bei**g Da Xue Xue Bao. 2011;43:414–5.

    PubMed  CAS  Google Scholar 

  20. Kavanaugh AF, Solomon DH. The American college of rheumatology ad hoc committee on immunologic testing guidelines. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum. 2002;47:546–55.

    Article  PubMed  CAS  Google Scholar 

  21. Reveille JD. Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus. 2004;13:290–7.

    Article  PubMed  CAS  Google Scholar 

  22. Birck R, Schmitt WH, Kaelsch IA, Van der Woude F. Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review. Am J Kidney Dis. 2006;47:15–23.

    Article  PubMed  Google Scholar 

  23. Tomasson G, Grayson PC, Mahr AD, LaValley M, Merkel PA. Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis—a meta-analysis. Rheumatology. 2012;51:100–9.

    Article  PubMed  CAS  Google Scholar 

  24. Damoiseaux J, Austen J, Cohen Tervaert JW. ANCA diagnostics in clinical practice: new developments. In: Amezcua-Guerra LM, editor. Advances in the diagnosis and treatment of vasculitis. Rijeka: Intech; 2012. p. 3–18.

    Google Scholar 

  25. Boomsma MM, Damoiseaux J, Stegeman CA, Kallenberg CGM, Patnaik M, Peter JB, Cohen Tervaert JW. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener’s granulomatosis. J Immunol Methods. 2003;274:27–35.

    Article  PubMed  CAS  Google Scholar 

  26. Damoiseaux J, Slot MC, Vaessen M, Stegeman CA, Van Paassen P, Cohen Tervaert JW. Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis. J Clin Immunol. 2005;25:202–8.

    Article  PubMed  CAS  Google Scholar 

  27. Damoiseaux J, Vaessen M, Knapen Y, Csernok E, Stegeman CA, Van Paassen P, Cohen Tervaert JW. Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA associated vasculitis and Goodpasture’s disease. Ann NY Acad Sci. 2007;1109:454–63.

    Article  PubMed  CAS  Google Scholar 

  28. Damoiseaux J, Dähnrich C, Rosemann A, Probst C, Komorowski L, Stegeman CA, Egerer K, Hiepe F, Van Paassen P, Stöcker W, Schlumberger W, Cohen Tervaert JW. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis. Ann Rheum Dis. 2009;68:228–33.

    Article  PubMed  CAS  Google Scholar 

  29. Kallenberg CGM, Stegeman CA, Bootsma H, Bijl M, Limburg PC. Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful? Lupus. 2006;15:397–402.

    Article  PubMed  CAS  Google Scholar 

  30. Radice A, Bianchi L, Sinico RA. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmun Rev. 2013;12:487–95.

    Article  PubMed  CAS  Google Scholar 

  31. Shoenfeld Y, Cervera R, Haass M, Kallenberg C, Khamashta M, Meroni PL, Piette J-C, Schmidt R, Wiik A. EASI—the European autoimmunity standardisation initiative. A new initiative that can contribute to agreed diagnostic models of diagnosing autoimmune disorders throughout Europe. Ann NY Acad Sci. 2007;1109:138–44.

    Article  PubMed  Google Scholar 

  32. Damoiseaux J, Cohen Tervaert JW, Derksen R, Hamann D, Hooijkaas H, Klasen I, Kallenberg C, Limburg P, Smeenk R. Autoantibody standardization in the Netherlands: the past, the present, and the future. Ann NY Acad Sci. 2009;1173:10–4.

    Article  PubMed  Google Scholar 

  33. Bingley PJ. Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab. 2010;95:25–33.

    Article  PubMed  CAS  Google Scholar 

  34. Roggenbuck D, Egerer K, Von Landenberg P, Hiemann R, Feist E, Burmester G-R, Dörner T. Antiphospholipid antibody profiling—time for a new technical approach? Autoimmun Rev. 2012;11:821–6.

    Article  PubMed  CAS  Google Scholar 

  35. Op De Beéck K, Vermeersch P, Verschueren P, Westhovens R, Mariën G, Blockmans D, Bossuyt X. Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmun Rev. 2012;12:137–43.

    Article  PubMed  Google Scholar 

  36. Pengo V, Tripodi G, Reber G, Rand JH, Ortel TL, Galli M, De Groot PG. Subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and standardisation committee of the international society of thrombosis and haemostasis. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost. 2009;7:1737–40.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Central Diagnostic Laboratory, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands

    Jan Damoiseaux

Authors
  1. Jan Damoiseaux
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan Damoiseaux.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Damoiseaux, J. Autoantibodies in the grocery shop: does quantity matter?. Immunol Res 56, 413–419 (2013). https://doi.org/10.1007/s12026-013-8419-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-013-8419-6

Keywords

Search

Navigation